A comparative study into the mechanisms of action of anti–tumor necrosis factor α, anti-CD4, and combined anti–tumor necrosis factor α/anti-CD4 treatment in early collagen-induced arthritis
✍ Scribed by Lilia Marinova-Mutafchieva; Richard O. Williams; Claudia Mauri; Lesley J. Mason; Marita J. Walmsley; Peter C. Taylor; Marc Feldmann; Ravinder N. Maini
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 205 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The authors are the principal investigators of the British Society of Rheumatology (BSR) Biologics Register. The BSR receives financial support for the Register from the manufacturers of biologic agents currently licensed for use in the treatment of patients with inflammatory rheumatic diseases. The
## Abstract ## Objective Limited data have been published on tolerance to and efficacy of classic or biologic disease‐modifying antirheumatic drugs in elderly patients with rheumatoid arthritis (RA). The goal of the present study was to evaluate the tolerance to and effectiveness of anti–tumor nec